Drug-resistant malaria: The era of ACT

被引:80
|
作者
Lin J.T. [1 ]
Juliano J.J. [2 ]
Wongsrichanalai C. [3 ]
机构
[1] Division of Infectious Diseases, Universityof North Carolina, School of Medicine, Chapel Hill
[2] Center for Infectious Diseases, University of North Carolina, CB7030, Chapel Hill, NC 27514
[3] Bangkok 10500
关键词
ACT; Antimalarial resistance; Artemisinin-based combination therapy; Drug-resistant malaria; Plasmodium falciparum;
D O I
10.1007/s11908-010-0099-y
中图分类号
学科分类号
摘要
As drug-resistant falciparum malaria has continued to evolve and spread worldwide, artemisinin-based combination therapies (ACT) have become the centerpiece of global malaria control over the past decade. This review discusses how advances in antimalarial drug resistance monitoring and rational use of the array of ACTs now available can maximize the impact of this highly efficacious therapy, even as resistance to artemisinins is emerging in Southeast Asia. © Springer Science+Business Media LLC 2010.
引用
收藏
页码:165 / 173
页数:8
相关论文
共 50 条
  • [41] Synthesis and Antimalarial Activity of 4-Methylaminoquinoline Compounds against Drug-Resistant Parasite
    Tiwari, Vinay Shankar
    Joshi, Prince
    Yadav, Kanchan
    Sharma, Anamika
    Chowdhury, Sushobhan
    Manhas, Ashan
    Kumar, Niti
    Tripathi, Renu
    Haq, Wahajul
    ACS OMEGA, 2021, 6 (20): : 12984 - 12994
  • [42] Rubber plantations and drug resistant malaria: a cross-sectional survey in Cambodia
    Thomson, Rebecca
    Sochea, Phok
    Sarath, Mak
    MacDonald, Amanda
    Pratt, Abigail
    Poyer, Steve
    Allen, Henrietta
    Kunthy, Sok
    Chamroeun, Sok
    Daro, Kim
    Samean, Sourn
    Panharith, Nou
    Ra, Sok
    Sovottha, Chan
    Mundy, Gary
    Yeung, Shunmay
    MALARIA JOURNAL, 2019, 18 (01)
  • [43] Amodiaquine-Ciprofloxacin: a potential combination therapy against drug resistant malaria
    Falajiki, Y. F.
    Akinola, O.
    Abiodun, O. O.
    Happi, C. T.
    Sowunmi, A.
    Gbotosho, G. O.
    PARASITOLOGY, 2015, 142 (06) : 849 - 854
  • [44] Malaria Modeling in the Era of Eradication
    Smith, Thomas A.
    Chitnis, Nakul
    Penny, Melissa
    Tanner, Marcel
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (04):
  • [45] Malaria Genomics in the Era of Eradication
    Neafsey, Daniel E.
    Volkman, Sarah K.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (08):
  • [46] The Antiproliferative Activity of Ferrocene Derivatives against Drug-Resistant Cancer Cell Lines: A Mini Review
    Li, Li
    Ma, Lin
    Sun, Jian
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2021, 21 (19) : 1756 - 1772
  • [47] Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia
    Al-Farsi, Hissa M.
    Al-Hashami, Zainab S.
    Bin Dajem, Saad M.
    Al-Sheikh, Adel Ali H.
    Al-Qahtani, Ahmed
    Beja-Pereira, Albano
    Idris, Mohamed A.
    Babiker, Hamza A.
    INFECTION GENETICS AND EVOLUTION, 2012, 12 (06) : 1253 - 1259
  • [48] Dinuclear and mononuclear metal(II) polypyridyl complexes against drug-sensitive and drug-resistant Plasmodium falciparum and their mode of action
    Lai, Jing Wei
    Maah, Mohd Jamil
    Tan, Kong Wai
    Sarip, Rozie
    Lim, Yvonne Ai Lian
    Ganguly, Rakesh
    Khaw, Loke Tim
    Ng, Chew Hee
    MALARIA JOURNAL, 2022, 21 (01)
  • [49] Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
    Witmer, Kathrin
    Dahalan, Farah A.
    Delves, Michael J.
    Yahiya, Sabrina
    Watson, Oliver J.
    Straschil, Ursula
    Chiwcharoen, Darunee
    Sornboon, Boodtee
    Pukrittayakamee, Sasithon
    Pearson, Richard D.
    Howick, Virginia M.
    Lawniczak, Mara K. N.
    White, Nicholas J.
    Dondorp, Arjen M.
    Okell, Lucy C.
    Chotivanich, Kesinee
    Ruecker, Andrea
    Baum, Jake
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (01)
  • [50] Artemisinin-resistant malaria
    White, N. J.
    Chotivanich, K.
    CLINICAL MICROBIOLOGY REVIEWS, 2024, 37 (04)